CIK: 0001595851 · Show all filings
Period: Q4 2014 (← Previous) (Next →)
Filing Date: Feb 18, 2015
Total Value: $208M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | 125,000 | $11.78M | 5.7% | $71.85 | 0.0% | Call | 375558103 |
| ZBH | ZIMMER HLDGS INC | 86,200 | $9.777M | 4.7% | $92.36 | +4.2% | COM | 98956P102 |
| SYK | STRYKER CORP | 100,000 | $9.433M | 4.5% | $77.85 | 0.0% | Call | 863667101 |
| — | ISIS PHARMACEUTICALS INC | 150,000 | $9.261M | 4.4% | — | — | Call | 464330109 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 125,000 | $6.75M | 3.2% | $46.08 | — | COM | 05337G107 |
| — | WRIGHT MED GROUP INC | 235,000 | $6.314M | 3.0% | $26.87 | — | COM | 98235T107 |
| GILD | GILEAD SCIENCES INC | 65,000 | $6.127M | 2.9% | $71.85 | 0.0% | COM | 375558103 |
| PBYI | PUMA BIOTECHNOLOGY INC | 30,000 | $5.678M | 2.7% | $214.23 | +3.6% | COM | 74587V107 |
| — | FLAMEL TECHNOLOGIES SA | 325,000 | $5.567M | 2.7% | $17.13 | — | SPONSORED ADR | 338488109 |
| — | CEPHEID | 100,000 | $5.414M | 2.6% | $54.14 | — | COM | 15670R107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 55,000 | $5.335M | 2.6% | $71.51 | +29.6% | COM | 02043Q107 |
| — | LA JOLLA PHARMACEUTICAL CO | 286,053 | $5.278M | 2.5% | $18.45 | — | COM PAR $.0001 2 | 503459604 |
| — | DEPOMED INC | 300,000 | $4.833M | 2.3% | $14.77 | — | COM | 249908104 |
| — | DYAX CORP | 325,000 | $4.57M | 2.2% | $14.06 | — | COM | 26746E103 |
| — | ACTAVIS PLC | 17,500 | $4.505M | 2.2% | $227.98 | — | SHS | G0083B108 |
| — | ZELTIQ AESTHETICS INC | 160,000 | $4.466M | 2.1% | $22.63 | — | COM | 98933Q108 |
| — | NEVRO CORP | 115,000 | $4.447M | 2.1% | $38.67 | — | COM | 64157F103 |
| PTCT | PTC THERAPEUTICS INC | 85,000 | $4.4M | 2.1% | $36.53 | +20.5% | COM | 69366J200 |
| — | PORTOLA PHARMACEUTICALS INC | 150,000 | $4.248M | 2.0% | $25.99 | — | COM | 737010108 |
| — | NUVASIVE INC | 90,000 | $4.244M | 2.0% | $40.34 | — | COM | 670704105 |
| — | INSYS THERAPEUTICS INC NEW | 100,000 | $4.216M | 2.0% | $42.16 | — | COM NEW | 45824V209 |
| — | HORIZON PHARMA PLC | 300,000 | $3.867M | 1.9% | $12.28 | — | SHS | G4617B105 |
| — | AIR METHODS CORP | 85,000 | $3.743M | 1.8% | $44.04 | — | COM PAR $.06 | 009128307 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 40,000 | $3.616M | 1.7% | $83.16 | 0.0% | COM | 09061G101 |
| — | KITE PHARMA INC | 60,000 | $3.46M | 1.7% | $57.67 | — | COM | 49803L109 |
| — | SALIX PHARMACEUTICALS INC | 30,000 | $3.448M | 1.7% | $114.93 | — | COM | 795435106 |
| — | AMAG PHARMACEUTICALS INC | 80,000 | $3.41M | 1.6% | $42.63 | — | COM | 00163U106 |
| — | ADVAXIS INC | 423,100 | $3.389M | 1.6% | $8.01 | — | COM | 007624208 |
| UHS | UNIVERSAL HLTH SVCS INC | 30,000 | $3.338M | 1.6% | $100.30 | 0.0% | CL B | 913903100 |
| SYK | STRYKER CORP | 35,000 | $3.302M | 1.6% | $77.85 | 0.0% | COM | 863667101 |
| — | ISIS PHARMACEUTICALS INC | 50,000 | $3.087M | 1.5% | — | — | Put | 464330109 |
| — | OPHTHOTECH CORP | 65,000 | $2.917M | 1.4% | $44.88 | — | COM | 683745103 |
| — | QUIDEL CORP | 100,000 | $2.892M | 1.4% | $26.87 | — | COM | 74838J101 |
| — | VALEANT PHARMACEUTICALS INTL | 20,000 | $2.862M | 1.4% | $131.20 | — | COM | 91911K102 |
| — | THERAPEUTICSMD INC | 636,800 | $2.834M | 1.4% | $5.07 | — | COM | 88338N107 |
| — | BLUEBIRD BIO INC | 30,000 | $2.752M | 1.3% | $35.89 | — | COM | 09609G100 |
| FOLD | AMICUS THERAPEUTICS INC | 300,000 | $2.496M | 1.2% | $6.86 | 0.0% | COM | 03152W109 |
| ARAY | ACCURAY INC | 300,000 | $2.265M | 1.1% | $7.05 | 0.0% | COM | 004397105 |
| — | DBV TECHNOLOGIES S A | 80,000 | $2.17M | 1.0% | $27.13 | — | SPONSORED ADR | 23306J101 |
| ISRG | INTUITIVE SURGICAL INC | 4,000 | $2.116M | 1.0% | $49.65 | +12.2% | COM NEW | 46120E602 |
| — | BIODELIVERY SCIENCES INTL IN | 175,000 | $2.104M | 1.0% | $12.02 | — | COM | 09060J106 |
| — | ARIAD PHARMACEUTICALS INC | 300,000 | $2.061M | 1.0% | $5.40 | — | COM | 04033A100 |
| ATRC | ATRICURE INC | 100,000 | $1.996M | 1.0% | $17.88 | -4.0% | COM | 04963C209 |
| — | ACHILLION PHARMACEUTICALS IN | 150,000 | $1.838M | 0.9% | — | — | Call | 00448Q201 |
| — | IMMUNOGEN INC | 300,000 | $1.83M | 0.9% | $6.10 | — | CALL | 45253H901 |
| — | BELLICUM PHARMACEUTICALS INC | 75,000 | $1.728M | 0.8% | $23.04 | — | COM | 079481107 |
| — | RAPTOR PHARMACEUTICAL CORP | 150,000 | $1.578M | 0.8% | $10.52 | — | COM | 75382F106 |
| MMSI | MERIT MED SYS INC | 75,000 | $1.3M | 0.6% | $14.79 | 0.0% | COM | 589889104 |
| — | TANDEM DIABETES CARE INC | 100,000 | $1.27M | 0.6% | $13.42 | — | COM | 875372104 |
| — | NANOSTRING TECHNOLOGIES INC | 90,000 | $1.254M | 0.6% | $18.50 | — | COM | 63009R109 |
| SNN | SMITH & NEPHEW PLC | 30,000 | $1.102M | 0.5% | $63.02 | — | SPDN ADR NEW | 83175M205 |
| — | AUSPEX PHARMACEUTICALS INC | 20,000 | $1.05M | 0.5% | $52.50 | — | COM | 05211J102 |
| — | WRIGHT MED GROUP INC | 185,000 | $884K | 0.4% | $2.33 | — | RIGHT 03/01/2019 | 98235T115 |
| — | OCERA THERAPEUTICS INC | 125,000 | $796K | 0.4% | $10.04 | — | COM | 67552A108 |
| — | BIOLASE INC | 300,000 | $789K | 0.4% | $2.41 | — | COM | 090911108 |
| — | CELLADON CORP | 40,000 | $781K | 0.4% | $19.52 | — | COM | 15117E107 |
| CPRX | CATALYST PHARM PARTNERS INC | 250,000 | $743K | 0.4% | $2.74 | 0.0% | COM | 14888U101 |
| — | ASSEMBLY BIOSCIENCES INC | 65,000 | $511K | 0.2% | $8.18 | — | COM | 045396108 |
| GBIM | GLOBEIMMUNE INC | 23,500 | $178K | 0.1% | $6.97 | 0.0% | COM | 37957B100 |